B I Gerwin

2.6k total citations · 1 hit paper
33 papers, 2.2k citations indexed

About

B I Gerwin is a scholar working on Pulmonary and Respiratory Medicine, Virology and Oncology. According to data from OpenAlex, B I Gerwin has authored 33 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 9 papers in Virology and 9 papers in Oncology. Recurrent topics in B I Gerwin's work include Occupational and environmental lung diseases (10 papers), HIV Research and Treatment (9 papers) and Cancer Research and Treatments (9 papers). B I Gerwin is often cited by papers focused on Occupational and environmental lung diseases (10 papers), HIV Research and Treatment (9 papers) and Cancer Research and Treatments (9 papers). B I Gerwin collaborates with scholars based in United States, Australia and Finland. B I Gerwin's co-authors include Roger R. Reddel, M G McMenamin, J.F. Lechner, Caitlin Harris, J S Rhim, R. Su, Ke Yan, Douglas E. Brash, Elisa A. Spillare and W P Bennett and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JNCI Journal of the National Cancer Institute and Journal of Virology.

In The Last Decade

B I Gerwin

33 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes.

1988 687 citations Roger R. Reddel, B I Gerwin et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B I Gerwin United States	22	981	789	635	355	283	33	2.2k
Gilbert F. Morris United States	25	1.1k 1.1×	488 0.6×	447 0.7×	230 0.6×	255 0.9×	54	2.0k
Yoshio Endo Japan	28	988 1.0×	1.2k 1.5×	457 0.7×	421 1.2×	326 1.2×	80	2.6k
Maurizio Bocchetta United States	24	946 1.0×	612 0.8×	788 1.2×	290 0.8×	135 0.5×	55	2.2k
J. S. Rhim United States	26	1.4k 1.4×	772 1.0×	451 0.7×	354 1.0×	193 0.7×	69	2.7k
Maija R.J. Kohonen‐Corish Australia	31	1.2k 1.2×	975 1.2×	651 1.0×	633 1.8×	480 1.7×	86	2.9k
Kurt Stromberg United States	27	992 1.0×	632 0.8×	173 0.3×	178 0.5×	463 1.6×	57	2.2k
M K Warren United States	23	805 0.8×	555 0.7×	182 0.3×	133 0.4×	1.6k 5.8×	37	2.9k
Jaromir Vlach United States	20	1.0k 1.1×	871 1.1×	99 0.2×	204 0.6×	812 2.9×	28	2.2k
Paul Coughlin Australia	21	965 1.0×	342 0.4×	159 0.3×	905 2.5×	530 1.9×	41	2.6k
Toshiyasu Hirama Japan	19	665 0.7×	535 0.7×	177 0.3×	154 0.4×	295 1.0×	47	1.9k

Countries citing papers authored by B I Gerwin

Since Specialization

Citations

This map shows the geographic impact of B I Gerwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B I Gerwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B I Gerwin more than expected).

Fields of papers citing papers by B I Gerwin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B I Gerwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B I Gerwin. The network helps show where B I Gerwin may publish in the future.

Co-authorship network of co-authors of B I Gerwin

This figure shows the co-authorship network connecting the top 25 collaborators of B I Gerwin. A scholar is included among the top collaborators of B I Gerwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B I Gerwin. B I Gerwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lechner, J.F., Yohannes Tesfaigzi, & B I Gerwin. (1997). Oncogenes and tumor-suppressor genes in mesothelioma--a synopsis.. Environmental Health Perspectives. 105(suppl 5). 1061–1067. 31 indexed citations

Tammilehto, L., et al.. (1996). High levels of MDM2 are not correlated with the presence of wild-type p53 in human malignant mesothelioma cell lines. British Journal of Cancer. 74(10). 1534–1540. 25 indexed citations

Gerwin, B I. (1996). Cytokine Signaling in Mesothelial Cells: Receptor Expression Closes the Autocrine Loop. American Journal of Respiratory Cell and Molecular Biology. 14(6). 505–507. 4 indexed citations

Gerwin, B I. (1994). Asbestos and the Mesothelial Cell: A Molecular Trail to Mitogenic Stimuli and Suppressor Gene Suspects. American Journal of Respiratory Cell and Molecular Biology. 11(5). 507–508. 13 indexed citations

Okamoto, Aikou, Douglas J. Demetrick, Elisa A. Spillare, et al.. (1994). p16 INK4 Mutations and Altered Expression in Human Tumors and Cell Lines. Cold Spring Harbor Symposia on Quantitative Biology. 59(0). 49–57. 25 indexed citations

Noguchi, Masayuki, Masaaki Murakami, William P. Bennett, et al.. (1993). Biological consequences of overexpression of a transfected c-erbB-2 gene in immortalized human bronchial epithelial cells.. PubMed. 53(9). 2035–43. 42 indexed citations

Metcalf, Robert A., Judith A. Welsh, W P Bennett, et al.. (1992). p53 and Kirsten-ras mutations in human mesothelioma cell lines.. PubMed. 52(9). 2610–5. 118 indexed citations

Gerwin, B I, Elisa A. Spillare, Kathleen Forrester, et al.. (1992). Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor beta 1.. Proceedings of the National Academy of Sciences. 89(7). 2759–2763. 102 indexed citations

Lehman, Teresa A., Roger R. Reddel, Elisa A. Spillare, et al.. (1991). Oncogenes and tumor-suppressor genes.. Environmental Health Perspectives. 93. 133–134. 16 indexed citations

10.

Husgafvel‐Pursiainen, Kirsti, L. Tammilehto, Matti Klockars, et al.. (1990). Asbestos-related malignant mesothelioma: growth, cytology, tumorigenicity and consistent chromosome findings in cell lines from five patients. Carcinogenesis. 11(4). 673–681. 74 indexed citations

11.

Gerwin, B I, Jorma Keski‐Oja, Michael Seddon, John F. Lechner, & Curtis C. Harris. (1990). TGF-beta 1 modulation of urokinase and PAI-1 expression in human bronchial epithelial cells. American Journal of Physiology-Lung Cellular and Molecular Physiology. 259(4). L262–L269. 32 indexed citations

12.

Ke, Yang, et al.. (1990). Cell density governs the ability of human bronchial epithelial cells to recognize serum and transforming growth factor beta-1 as squamous differentiation-inducing agents.. PubMed. 137(4). 833–43. 31 indexed citations

13.

Reddel, Roger R., Louise Malan‐Shibley, B I Gerwin, Robert A. Metcalf, & C C Harris. (1989). Tumorigenicity of Human Mesothelial Cell Line Transfected With EJ-ras Oncogene. JNCI Journal of the National Cancer Institute. 81(12). 945–948. 22 indexed citations

14.

Levin, Judith G., et al.. (1988). Functional organization of the murine leukemia virus reverse transcriptase: characterization of a bacterially expressed AKR DNA polymerase deficient in RNase H activity. Journal of Virology. 62(11). 4376–4380. 40 indexed citations

15.

Gabrielson, Edward, John F. Lechner, B I Gerwin, Moira A. LaVeck, & Curtis C. Harris. (1987). Growth Factors for Mesothelial and Mesothelioma Cells. CHEST Journal. 91(3). 17s–18s. 7 indexed citations

16.

Cooper, C.S., et al.. (1983). Sites of single-strand breaks in DNA treated with a diol-epoxide of benz[a]anthracene. Carcinogenesis. 4(12). 1645–1649. 2 indexed citations

17.

Bassin, Robert H., et al.. (1980). Macromolecular requirements for abrogation of Fv-1 restriction by murine leukemia viruses. Journal of Virology. 35(2). 287–297. 11 indexed citations

18.

Bassin, Robert H., et al.. (1978). Abrogation of Fv-1b restriction with murine leukemia viruses inactivated by heat or by gamma irradiation. Journal of Virology. 26(2). 306–315. 32 indexed citations

19.

Kashmiri, S. V. S., Alan Rein, Robert H. Bassin, B I Gerwin, & S Gisselbrecht. (1977). Donation of N- or B-tropic phenotype to NB-tropic murine leukemia virus during mixed infections. Journal of Virology. 22(3). 626–633. 30 indexed citations

20.

Bassin, Robert H., et al.. (1972). Isolation of a Continuous Epithelioid Cell Line, HBT-3, from a Human Breast Carcinoma. Experimental Biology and Medicine. 141(2). 673–680. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact